Cardiovascular System Assessments

Published on 23/05/2015 by admin

Filed under Pulmolory and Respiratory

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1837 times

Cardiovascular System Assessments

Chapter Objectives

After reading this chapter, you will be able to:

• Describe the ECG pattern of a normal cardiac cycle, and include the following:

• P wave

• QRS complex

• T wave

• Normal heart rate

• Describe the characteristics of the following arrhythmias:

• Sinus bradycardia

• Sinus tachycardia

• Sinus arrhythmia

• Atrial flutter

• Atrial fibrillation

• Premature ventricular contractions

• Ventricular tachycardia

• Ventricular flutter

• Ventricular fibrillation

• Asystole (cardiac standstill)

• Describe the noninvasive hemodynamic monitoring assessments, and include the following:

• The definition of hemodynamics

• The evaluation of the patient’s heart rate, cardiac output, blood pressure, and perfusion state

• Describe the basic pathophysiologic mechanisms for the following hemodynamic changes that frequently develop during the acute stages of respiratory disease:

• Increased heart rate (pulse), cardiac output, and blood pressure

• Decreased perfusion state

• Describe the invasive hemodynamic monitoring assessments, and include the following:

• Pulmonary artery catheter measurements

• Arterial catheter measurements

• Central venous pressure catheter measurements

• Describe how the hypoxemia, acidemia, or pulmonary vascular obstruction associated with respiratory disease alters the hemodynamic status.

• Define key terms and complete self-assessment questions at the end of the chapter and on Evolve.

Because the transport of oxygen to the tissue cells and the delivery of carbon dioxide to the lungs are functions of the cardiovascular system, a basic knowledge and understanding of (1) normal electrocardiogram (ECG) patterns, (2) common heart arrhythmias, (3) noninvasive hemodynamic monitoring assessments, (4) invasive hemodynamic monitoring assessments, and (5) determinants of cardiac output are essential components of patient assessment.*

The Electrocardiogram

Because the respiratory care practitioner frequently works with critically ill patients who are on cardiac monitors, a basic understanding of normal and common abnormal ECG patterns is important. An ECG monitors, both visually and on recording paper, the electrical activity of the heart. Figure 6-1 illustrates the ECG pattern of a normal cardiac cycle. The P wave reflects depolarization of the atria. The QRS complex represents the depolarization of the ventricles, and the T wave represents ventricular repolarization.

In normal adults the heart rate is between 60 and 100 beats per minute (bpm). In normal infants the heart rate is 130 to 150 bpm. A number of methods can be used to calculate the heart rate. For example, when the rhythm is regular, the heart rate can be determined at a glance by counting the number of large boxes (on the ECG strip) between two QRS complexes and then dividing this number into 300. Therefore if an ECG strip consistently shows four large boxes between each pair of QRS complexes, the heart rate is 75 bpm (300 ÷ 4 = 75). When the rhythm is irregular, the heart rate can be determined by counting the QRS complexes on a 6-second strip and multiplying by 10. The following heart arrhythmias are commonly seen and should be recognized by the respiratory care practitioner.

Common Heart Arrhythmias

Sinus Bradycardia

In sinus bradycardia the heart rate is less than 60 bpm. Bradycardia means “slow heart.” Sinus bradycardia has a normal P-QRS-T pattern, and the rhythm is regular (Figure 6-2). Athletes often normally demonstrate this finding because of increased cardiac stroke volume and other poorly understood mechanisms. Common pathologic causes of sinus bradycardia include a weakened or damaged sinoatrial (SA) node, severe or chronic hypoxemia, increased intracranial pressure, obstructive sleep apnea, and certain drugs (most notably the beta-blockers). Sinus bradycardia may lead to decreased cardiac output and blood pressure. In severe cases, sinus bradycardia may lead to a decreased vascular perfusion state and tissue hypoxia. The patient may demonstrate a weak or absent pulse, poor capillary refill, cold and clammy skin, and a depressed sensorium.

Sinus Tachycardia

In sinus tachycardia the heart rate is greater than 100 bpm. Tachycardia means “fast heart.” Sinus tachycardia has a normal P-QRS-T pattern, and the rhythm is regular (Figure 6-3). Sinus tachycardia is the normal physiologic response to stress and exercise. Common causes of sinus tachycardia include hypoxemia, severe anemia, hyperthermia, massive hemorrhage, pain, fear, anxiety, hyperthyroidism, and sympathomimetic or parasympatholytic drug administration.

Sinus Arrhythmia

In sinus arrhythmia the heart rate varies by more than 10% from beat to beat. The P-QRS-T pattern is normal (Figure 6-4), but the interval between groups of complexes (i.e., the R-R interval) varies. Sinus arrhythmia is a normal rhythm in children and young adults. The patient’s pulse will often increase during inspiration and decrease during expiration. No treatment is required unless significant alteration occurs in the patient’s arterial blood pressure.

Atrial Flutter

In atrial flutter the normal P wave is absent and replaced by two or more regular sawtooth waves. The QRS complex is normal and the ventricular rate may be regular or irregular, depending on the relationship of the atrial to the ventricular beats. Figure 6-5 shows an atrial flutter with a regular rhythm with a 4 : 1 conduction ratio (i.e., four atrial beats for every ventricular beat). The atrial rate is usually constant, between 250 and 350 bpm, whereas the ventricular rate is in the normal range. Causes of atrial flutter include hypoxemia, a damaged SA node, and congestive heart failure.

Atrial Fibrillation

In atrial fibrillation the atrial contractions are disorganized and ineffective, and the normal P wave is absent (Figure 6-6). The atrial rate ranges from 350 to 700 bpm. The QRS complex is normal, and the ventricular rate ranges from 100 to 200 bpm. Causes of atrial fibrillation include hypoxemia and a damaged SA node. Atrial fibrillation may reduce the cardiac output by 20% because of a loss of atrial filling (the so-called “atrial kick”).

Premature Ventricular Contractions

The premature ventricular contraction (PVC) is not preceded by a P wave. The QRS complex is wide, bizarre, and unlike the normal QRS complex (Figure 6-7). The regular heart rate is altered by the PVC. The heart rhythm may be quite irregular when there are many PVCs. PVCs can occur at any rate. They often occur in pairs, after every normal heartbeat (bigeminal PVCs), and after every two normal heartbeats (trigeminal PVCs). Common causes of PVCs include intrinsic myocardial disease, hypoxemia, acidemia, hypokalemia, and congestive heart failure. PVCs also may be a sign of theophylline or alpha- or beta-agonist toxicity.

Ventricular Tachycardia

In ventricular tachycardia the P wave is generally indiscernible, and the QRS complex is wide and bizarre in appearance (Figure 6-8). The T wave may not be separated from the QRS complex. The ventricular rate ranges from 150 to 250 bpm, and the rate is regular or slightly irregular. The patient’s blood pressure is often decreased during ventricular tachycardia.

Ventricular Flutter

In ventricular flutter the QRS complex has the appearance of a wide sine wave (regular, smooth, rounded ventricular wave; Figure 6-9). The rhythm is regular or slightly irregular. The rate is 250 to 350 bpm. There is usually no discernible peripheral pulse associated with ventricular flutter.

Noninvasive Hemodynamic Monitoring Assessments

Hemodynamics is the study of forces that influence the circulation of blood. The general hemodynamic status of the patient can be monitored noninvasively at the bedside by assessing the heart rate (via an ECG monitor, auscultation, or pulse), blood pressure, and perfusion state. During the acute stages of respiratory disease, the patient frequently demonstrates the hemodynamic changes described in the following paragraphs.

Increased Heart Rate (Pulse), Cardiac Output, and Blood Pressure

Increased heart rate, pulse, and blood pressure develop frequently during the acute stages of pulmonary disease. This can result from the indirect response of the heart to hypoxic stimulation of the peripheral chemoreceptors, primarily the carotid bodies. When the carotid bodies are stimulated, reflex signals are sent to the respiratory muscles, which in turn activate the so-called pulmonary reflex, which triggers tachycardia and an increased cardiac output and blood pressure. The increased cardiac output is a compensatory mechanism that at least partially counteracts the hypoxemia produced by the pulmonary shunting in respiratory disorders.

This process is perhaps best understood by assuming that the body’s oxygen use remains relatively constant over time. When the cardiac output increases during a period of steady metabolic requirements, oxygen transport increases, and the amount of oxygen extracted from each 100 mL of blood decreases. This results in an increase in the oxygen saturation of the returning venous blood, which in turn reduces the hypoxemia produced by the shunted blood. In other words, venous blood that perfuses underventilated alveoli will have less of a shunt effect if the oxygen content of the systemic venous blood is 13 vol% compared with, say, 10 vol%.

Other causes of increased heart rate, pulse, and blood pressure include severe anemia, high fever, anxiety, massive hemorrhage, certain cardiac arrhythmias, and hyperthyroidism. When the heart rate increases beyond 150 to 175 bpm, cardiac output and blood pressure begin to decline (the Starling relationship).

Invasive Hemodynamic Monitoring Assessments

Invasive hemodynamic monitoring is used in the assessment and treatment of critically ill patients. Invasive hemodynamic monitoring includes the measurement of (1) intracardiac pressures and flows via a pulmonary artery catheter, (2) arterial pressure via an arterial catheter, and (3) central venous pressure via a central venous catheter. Monitoring of these values provides rapid and precise measurements (assessment data) of the patient’s cardiovascular function—which in turn are used to down-regulate or up-regulate the patient’s treatment plan in a timely manner.

Pulmonary Artery Catheter

The pulmonary artery catheter (Swan-Ganz catheter) is a balloon-tipped, flow-directed catheter that is inserted at the patient’s bedside; the respiratory care professional monitors the pressure waveform as the catheter, with the balloon inflated, is guided by blood flow through the right atrium and right ventricle into the pulmonary artery (Figure 6-11). The pulmonary artery catheter is used directly to measure the right atrial pressure (via the proximal port), pulmonary artery pressure (via the distal port), left atrial pressure (indirectly via the pulmonary capillary wedge pressure), and cardiac output (via the thermodilution technique).

Central Venous Pressure Catheter

The central venous pressure (CVP) catheter readily measures the CVP and the right ventricular filling pressure. It serves as an excellent monitor of right ventricular function. An increased CVP reading is commonly seen in patients who (1) have left ventricular heart failure (e.g., pulmonary edema), (2) are receiving excessively high positive pressure mechanical breaths, (3) have cor pulmonale, or (4) have a severe flail chest, pneumothorax, or pleural effusion.

Table 6-1 summarizes the hemodynamic parameters that can be measured directly. Table 6-2 lists the hemodynamic parameters that can be calculated from results obtained from the direct measurements.

Table 6-1

Hemodynamic Values Measured Directly

Hemodynamic Value Abbreviation Normal Range
Central venous pressure CVP 0-8 mm Hg
Right atrial pressure RAP 0-8 mm Hg
Mean pulmonary artery pressure image 10-20 mm Hg
Pulmonary capillary wedge pressure (also called pulmonary artery wedge; pulmonary artery occlusion) PCWP 4-12 mm Hg
PAW  
PAO  
Cardiac output CO 4-6 L/min

image

Table 6-2

Hemodynamic Values Calculated from Direct Hemodynamic Measurements

Hemodynamic Value Abbreviation Normal Range
Stroke volume SV 40-80 ml
Stroke volume index SVI 40 ± ml/beat/m2
Cardiac index CI 3.0 ± 0.5 L/min/m2
Right ventricular stroke work index RVSWI 7-12 g/m2
Left ventricular stroke work index LVSWI 40-60 g/m2
Pulmonary vascular resistance PVR 50-150 dynes × sec × cm−5
Systemic vascular resistance SVR 800-1500 dynes × sec × cm−5

Hemodynamic Monitoring in Respiratory Diseases

Because respiratory disorders can have a profound effect on the structure and function of the pulmonary vascular bed, right side of the heart, left side of the heart, or a combination of all three, the data generated by the previously described invasive hemodynamic monitors are commonly used in the assessment and treatment of these patients. For example, respiratory diseases associated with severe or chronic hypoxemia, acidemia, or pulmonary vascular obstruction can increase the pulmonary vascular resistance (PVR) significantly. An increased PVR, in turn, can lead to a variety of secondary hemodynamic changes such as increased CVP, RAP, image, RVSWI, and decreased CO, SV, SVI, CI, and LVSWI (see Tables 6-1 and 6-2 for abbreviation definitions). Table 6-3 lists common hemodynamic changes seen in pulmonary diseases known to alter the patient’s hemodynamic status.

Table 6-3

Hemodynamic Changes Commonly Seen in Respiratory Diseases

Disorder Hemodynamic Indices
CVP RAP image PCWP CO SV SVI CI RVSWI LVSWI PVR SVR
COPD ↑↑ *
 Chronic bronchitis                        
 Emphysema                        
 Cystic fibrosis                        
 Bronchiectasis                        
Pulmonary edema (cardiogenic) ↑↑
Pulmonary embolism ↑↑
Adult respiratory distress syndrome (ARDS)—severe ∼↑ ∼↑ ∼↑ ∼↑ ∼↑
Lung collapse
 Flail chest                        
 Pneumothorax                        
 Pleural disease (e.g., hemothorax)                        
Kyphoscoliosis
Pneumoconiosis ↑↑
Chronic interstitial lung diseases ↑↑
Cancer of the lung (tumor mass)
Hypovolemia ↓↓
Hypervolemia (burns) ↑↑
Right heart failure (cor pulmonale) ↑↑ ↑↑

image

*∼, Unchanged.